Polyphenols target miRNAs as a therapeutic strategy for diabetic complications

References

• Ahmad, I, and M. Hoda. 2020. Attenuation of diabetic retinopathy and neuropathy by resveratrol: review on its molecular mechanisms of action. Life Sciences 245:117350. doi: 10.1016/j.lfs.2020.117350.
   PubMed Web of Science ®Google Scholar
• Al-Kafaji, G., G. Al-Mahroos, H. A. Al-Muhtaresh, C. Skrypnyk, M. A. Sabry, and A. R. Ramadan. 2016. Decreased expression of circulating microrna-126 in patients with type 2 diabetic nephropathy: a potential blood-based biomarker. Experimental and Therapeutic Medicine 12 (2):815–22. doi: 10.3892/etm.2016.3395.
   PubMed Web of Science ®Google Scholar
• Al-Rejaie, S. S., A. M. Aleisa, H. M. Abuohashish, M. Y. Parmar, M. S. Ola, A. A. Al-Hosaini, and M. M. Ahmed. 2015. Naringenin neutralises oxidative stress and nerve growth factor discrepancy in experimental diabetic neuropathy. Neurological Research 37 (10):924–33. doi: 10.1179/1743132815y.0000000079.
   PubMed Web of Science ®Google Scholar
• An, X., L. Zhang, Y. Yuan, B. Wang, Q. Yao, L. Li, J. Zhang, M. He, and J. Zhang. 2017. Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression. Scientific Reports 7 (1):6413. doi: 10.1038/s41598-017-06844-2.
   PubMedGoogle Scholar
• Andriambeloson, E., C. Baillet, P. A. Vitte, G. Garotta, M. Dreano, and N. Callizot. 2006. Interleukin‐6 attenuates the development of experimental diabetes‐related neuropathy. Neuropathology: Official Journal of the Japanese Society of Neuropathology 26 (1):32–42. doi: 10.1111/j.1440-1789.2006.00651.x.
   PubMed Web of Science ®Google Scholar
• Annese, T., R. Tamma, M. De Giorgis, and D. Ribatti. 2020. Micrornas biogenesis, functions and role in tumor angiogenesis. Frontiers in Oncology 10:581007. doi: 10.3389/fonc.2020.581007.
   PubMed Web of Science ®Google Scholar
• Arneth, B., R. Arneth, and M. Shams. 2019. Metabolomics of type 1 and type 2 diabetes. International Journal of Molecular Sciences 20 (10):2467. doi: 10.3390/ijms20102467.
   Web of Science ®Google Scholar
• Asrih, M, and S. Steffens. 2013. Emerging role of epigenetics and mirna in diabetic cardiomyopathy. Cardiovascular Pathology: The Official Journal of the Society for Cardiovascular Pathology 22 (2):117–25. doi: 10.1016/j.carpath.2012.07.004.
   PubMed Web of Science ®Google Scholar
• Assmann, T. S., M. Recamonde-Mendoza, B. M. de Souza, A. C. Bauer, and D. Crispim. 2018. Micrornas and diabetic kidney disease: systematic review and bioinformatic analysis. Molecular and Cellular Endocrinology 477:90–102. doi: 10.1016/j.mce.2018.06.005.
   PubMed Web of Science ®Google Scholar
• Atale, N., D. Yadav, V. Rani, and J. O. Jin. 2020. Pathophysiology, clinical characteristics of diabetic cardiomyopathy: therapeutic potential of natural polyphenols. Frontiers in Nutrition 7:564352. doi: 10.3389/fnut.2020.564352.
   PubMed Web of Science ®Google Scholar
• Ayavoo, T., K. Murugesan, and A. Gnanasekaran. 2021. Roles and mechanisms of stem cell in wound healing. Stem Cell Investigation 8:4. doi: 10.21037/sci-2020-027.
   PubMedGoogle Scholar
• Bartel, D. P. 2004. Micrornas: genomics, biogenesis, mechanism, and function. Cell 116 (2):281–97. doi: 10.1016/S0092-8674(04)00045-5.
   PubMed Web of Science ®Google Scholar
• Beltrami, C., K. Simpson, M. Jesky, A. Wonnacott, C. Carrington, P. Holmans, L. Newbury, R. Jenkins, T. Ashdown, C. Dayan, et al. 2018. Association of elevated urinary mir-126, mir-155, and mir-29b with diabetic kidney disease. The American Journal of Pathology 188 (9):1982–92. doi: 10.1016/j.ajpath.2018.06.006.
   PubMed Web of Science ®Google Scholar
• Bhattacharjee, N., S. Barma, N. Konwar, S. Dewanjee, and P. Manna. 2016. Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: an update. European Journal of Pharmacology 791:8–24. doi: 10.1016/j.ejphar.2016.08.022.
   PubMed Web of Science ®Google Scholar
• Bi, X., L. Zhou, Y. Liu, J. Gu, and Q. S. Mi. 2022. Microrna-146a deficiency delays wound healing in normal and diabetic mice. Advances in Wound Care 11 (1):19–27. doi: 10.1089/wound.2020.1165.
   Web of Science ®Google Scholar
• Bladé, C., L. Baselga-Escudero, M. J. Salvadó, and A. Arola-Arnal. 2013. Mirnas, polyphenols, and chronic disease. Molecular Nutrition & Food Research 57 (1):58–70. doi: 10.1002/mnfr.201200454.
   PubMed Web of Science ®Google Scholar
• Blattner, S. M, and M. Kretzler. 2005. Integrin-linked kinase in renal disease: connecting cell-matrix interaction to the cytoskeleton. Current Opinion in Nephrology and Hypertension 14 (4):404–10. doi: 10.1097/01.mnh.0000172730.67746.5b.
   PubMed Web of Science ®Google Scholar
• Cao, D., M. Zhao, C. Wan, Q. Zhang, T. Tang, J. Liu, Q. Shao, B. Yang, J. He, and C. Jiang. 2019. Role of tea polyphenols in delaying hyperglycemia-induced senescence in human glomerular mesangial cells via mir-126/akt-p53-p21 pathways. International Urology and Nephrology 51 (6):1071–8. doi: 10.1007/s11255-019-02165-7.
   PubMed Web of Science ®Google Scholar
• Cao, Y., J. Hu, J. Sui, L. Jiang, Y. Cong, and G. Ren. 2018. Quercetin is able to alleviate tgf-β-induced fibrosis in renal tubular epithelial cells by suppressing mir-21. Experimental and Therapeutic Medicine 16 (3):2442–8. doi: 10.3892/etm.2018.6489.
   PubMed Web of Science ®Google Scholar
• Carpi, S., E. Scoditti, M. Massaro, B. Polini, C. Manera, M. Digiacomo, J. E. Salsano, G. Poli, T. Tuccinardi, S. Doccini, et al. 2019. The extra-virgin olive oil polyphenols oleocanthal and oleacein counteract inflammation-related gene and mirna expression in adipocytes by attenuating nf-κb activation. Nutrients 11 (12):2855. doi: 10.3390/nu11122855.
   PubMed Web of Science ®Google Scholar
• Çetinkalp, Ş., E. H. Gökçe, I. Şimşir, S. Tuncay Tanrıverdi, F. Doğan, Ç. Biray Avcı, İ. Eroğlu, T. Utku, C. Gündüz, and Ö. Özer. 2021. Comparative evaluation of clinical efficacy and safety of collagen laminin-based dermal matrix combined with resveratrol microparticles (dermalix) and standard wound care for diabetic foot ulcers. The International Journal of Lower Extremity Wounds 20 (3):217–26. doi: 10.1177/1534734620907773.
   PubMed Web of Science ®Google Scholar
• Chakrabarti, S. 2016. Microrna15a - a molecule modulating multiple pathologies in diabetic retinopathy. EBioMedicine 11:13–4. doi: 10.1016/j.ebiom.2016.08.017.
   PubMed Web of Science ®Google Scholar
• Chen, J.-F., E. P. Murchison, R. Tang, T. E. Callis, M. Tatsuguchi, Z. Deng, M. Rojas, S. M. Hammond, M. D. Schneider, C. H. Selzman, et al. 2008. Targeted deletion of dicer in the heart leads to dilated cardiomyopathy and heart failure. Proceedings of the National Academy of Sciences of the United States of America 105 (6):2111–6. doi: 10.1073/pnas.0710228105.
   PubMed Web of Science ®Google Scholar
• Chen, J., C. Cui, X. Yang, J. Xu, P. Venkat, A. Zacharek, P. Yu, and M. Chopp. 2017. Mir-126 affects brain-heart interaction after cerebral ischemic stroke. Translational Stroke Research 8 (4):374–85. doi: 10.1007/s12975-017-0520-z.
   PubMed Web of Science ®Google Scholar
• Chen, J., C. Li, W. Liu, B. Yan, X. Hu, and F. Yang. 2019. Mirna-155 silencing reduces sciatic nerve injury in diabetic peripheral neuropathy. Journal of Molecular Endocrinology 63 (3):227–38. doi: 10.1530/jme-19-0067.
   PubMed Web of Science ®Google Scholar
• Chen, S., H. Jiang, X. Wu, and J. Fang. 2016. Therapeutic effects of quercetin on inflammation, obesity, and type 2 diabetes. Mediators of Inflammation 2016:9340637. doi: 10.1155/2016/9340637.
   PubMed Web of Science ®Google Scholar
• Chen, S., P. Puthanveetil, B. Feng, S. J. Matkovich, G. W. Dorn, 2nd, and S. Chakrabarti. 2014. Cardiac mir-133a overexpression prevents early cardiac fibrosis in diabetes. Journal of Cellular and Molecular Medicine 18 (3):415–21. doi: 10.1111/jcmm.12218.
   PubMed Web of Science ®Google Scholar
• Climent, M., G. Viggiani, Y. W. Chen, G. Coulis, and A. Castaldi. 2020. Microrna and ros crosstalk in cardiac and pulmonary diseases. International Journal of Molecular Sciences 21 (12):4370. doi: 10.3390/ijms21124370.
   PubMed Web of Science ®Google Scholar
• Coppari, S., M. Colomba, D. Fraternale, V. Brinkmann, M. Romeo, M. B. L. Rocchi, B. D. Giacomo, M. Mari, L. Guidi, S. Ramakrishna, et al. 2021. Antioxidant and anti-inflammaging ability of prune (Prunus spinosa L.) extract result in improved wound healing efficacy. Antioxidants (Basel, Switzerland) 10 (3):374. doi: 10.3390/antiox10030374.
   PubMedGoogle Scholar
• Dai, B., H. Li, J. Fan, Y. Zhao, Z. Yin, X. Nie, D. W. Wang, and C. Chen. 2018. Mir-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin. Cardiovascular Diabetology 17 (1):123. doi: 10.1186/s12933-018-0767-z.
   PubMedGoogle Scholar
• Dai, C., S. Jiang, C. Chu, M. Xin, X. Song, and B. Zhao. 2019. Baicalin protects human retinal pigment epithelial cell lines against high glucose-induced cell injury by up-regulation of microrna-145. Experimental and Molecular Pathology 106:123–30. doi: 10.1016/j.yexmp.2019.01.002.
   PubMed Web of Science ®Google Scholar
• Dantas da Costa, E., E. R. Polina, D. Crispim, R. C. Sbruzzi, D. Lavinsky, F. Mallmann, N. C. Martinelli, L. H. Canani, and K. G. Dos Santos. 2019. Plasma levels of mir-29b and mir-200b in type 2 diabetic retinopathy. Journal of Cellular and Molecular Medicine 23 (2):1280–7. doi: 10.1111/jcmm.14030.
   PubMed Web of Science ®Google Scholar
• Das, F., S. Maity, N. Ghosh-Choudhury, B. S. Kasinath, and G. Ghosh Choudhury. 2019. Deacetylation of s6 kinase promotes high glucose-induced glomerular mesangial cell hypertrophy and matrix protein accumulation. The Journal of Biological Chemistry 294 (24):9440–60. doi: 10.1074/jbc.RA118.007023.
   PubMed Web of Science ®Google Scholar
• Das, S., M. Ferlito, O. A. Kent, K. Fox-Talbot, R. Wang, D. Liu, N. Raghavachari, Y. Yang, S. J. Wheelan, E. Murphy, et al. 2012. Nuclear mirna regulates the mitochondrial genome in the heart. Circulation Research 110 (12):1596–603., doi: 10.1161/CIRCRESAHA.112.267732.
   PubMed Web of Science ®Google Scholar
• Dewanjee, S, and N. Bhattacharjee. 2018. Microrna: a new generation therapeutic target in diabetic nephropathy. Biochemical Pharmacology 155:32–47. doi: 10.1016/j.bcp.2018.06.017.
   PubMed Web of Science ®Google Scholar
• Dillmann, W. H. 2019. Diabetic cardiomyopathy. Circulation Research 124 (8):1160–2. doi: 10.1161/circresaha.118.314665.
   PubMed Web of Science ®Google Scholar
• Dimas, G. G., T. P. Didangelos, and D. M. Grekas. 2017. Matrix gelatinases in atherosclerosis and diabetic nephropathy: progress and challenges. Current Vascular Pharmacology 15 (6):557–65. doi: 10.2174/1570161115666170202162345.
   PubMed Web of Science ®Google Scholar
• Dixon, D, and M. Edmonds. 2021. Managing diabetic foot ulcers: pharmacotherapy for wound healing. Drugs 81 (1):29–56. doi: 10.1007/s40265-020-01415-8.
   PubMed Web of Science ®Google Scholar
• Du, L. Q., Y. Wang, H. Wang, J. Cao, Q. Liu, and F. Y. Fan. 2011. Knockdown of rad51 expression induces radiation- and chemo-sensitivity in osteosarcoma cells. Medical Oncology (Northwood, London, England) 28 (4):1481–7. doi: 10.1007/s12032-010-9605-1.
   PubMed Web of Science ®Google Scholar
• Ebrahimpour, S., A. Esmaeili, F. Dehghanian, and S. Beheshti. 2020. Effects of quercetin-conjugated with superparamagnetic iron oxide nanoparticles on learning and memory improvement through targeting micrornas/nf-κb pathway. Scientific Reports 10 (1):15070. doi: 10.1038/s41598-020-71678-4.
   PubMed Web of Science ®Google Scholar
• Ebrahimpour, S., S. B. Shahidi, M. Abbasi, Z. Tavakoli, and A. Esmaeili. 2020. Quercetin-conjugated superparamagnetic iron oxide nanoparticles (qcspions) increases nrf2 expression via mir-27a mediation to prevent memory dysfunction in diabetic rats. Scientific Reports 10 (1):15957. doi: 10.1038/s41598-020-71971-2.
   PubMed Web of Science ®Google Scholar
• Fan, B., M. Chopp, Z. G. Zhang, and X. S. Liu. 2020. Emerging roles of micrornas as biomarkers and therapeutic targets for diabetic neuropathy. Frontiers in Neurology 11:558758. doi: 10.3389/fneur.2020.558758.
   PubMed Web of Science ®Google Scholar
• Fan, B., M. Chopp, Z. G. Zhang, and X. S. Liu. 2021. Treatment of diabetic peripheral neuropathy with engineered mesenchymal stromal cell-derived exosomes enriched with microrna-146a provide amplified therapeutic efficacy. Experimental Neurology 341:113694. doi: 10.1016/j.expneurol.2021.113694.
   PubMed Web of Science ®Google Scholar
• Fang, P., M. Yu, M. Shi, P. Bo, X. Gu, and Z. Zhang. 2020. Baicalin and its aglycone: a novel approach for treatment of metabolic disorders. Pharmacological Reports: PR 72 (1):13–23. doi: 10.1007/s43440-019-00024-x.
   PubMed Web of Science ®Google Scholar
• Feldman, E. L., B. C. Callaghan, R. Pop-Busui, D. W. Zochodne, D. E. Wright, D. L. Bennett, V. Bril, J. W. Russell, and V. Viswanathan. 2019. Diabetic neuropathy. Nature Reviews. Disease Primers 5 (1):42. doi: 10.1038/s41572-019-0097-9.
   PubMedGoogle Scholar
• Feng, Y., L. Chen, Q. Luo, M. Wu, Y. Chen, and X. Shi. 2018. Involvement of microrna-146a in diabetic peripheral neuropathy through the regulation of inflammation. Drug Design, Development and Therapy 12:171–7. doi: 10.2147/DDDT.S157109.
   PubMed Web of Science ®Google Scholar
• Finnerup, N. B., S. H. Sindrup, and T. S. Jensen. 2010. The evidence for pharmacological treatment of neuropathic pain. Pain 150 (3):573–81. doi: 10.1016/j.pain.2010.06.019.
   PubMed Web of Science ®Google Scholar
• Galiniak, S., D. Aebisher, and D. Bartusik-Aebisher. 2019. Health benefits of resveratrol administration. Acta Biochimica Polonica 66 (1):13–21. doi: 10.18388/abp.2018_2749.
   PubMed Web of Science ®Google Scholar
• Garo, L. P, and G. Murugaiyan. 2016. Contribution of micrornas to autoimmune diseases. Cellular and Molecular Life Sciences: CMLS 73 (10):2041–51. doi: 10.1007/s00018-016-2167-4.
   PubMed Web of Science ®Google Scholar
• Garzon, R., S. Liu, M. Fabbri, Z. Liu, C. E. Heaphy, E. Callegari, S. Schwind, J. Pang, J. Yu, N. Muthusamy, et al. 2009. Microrna-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly dnmt3a and 3b and indirectly dnmt1. Blood 113 (25):6411–8. doi: 10.1182/blood-2008-07-170589.
   PubMed Web of Science ®Google Scholar
• Ghosh, N, and R. Katare. 2018. Molecular mechanism of diabetic cardiomyopathy and modulation of microrna function by synthetic oligonucleotides. Cardiovascular Diabetology 17 (1):43. doi: 10.1186/s12933-018-0684-1.
   PubMedGoogle Scholar
• Godos, J., S. Marventano, A. Mistretta, F. Galvano, and G. Grosso. 2017. Dietary sources of polyphenols in the mediterranean healthy eating, aging and lifestyle (meal) study cohort. International Journal of Food Sciences and Nutrition 68 (6):750–6. doi: 10.1080/09637486.2017.1285870.
   PubMed Web of Science ®Google Scholar
• Gomez, I. G., D. A. MacKenna, B. G. Johnson, V. Kaimal, A. M. Roach, S. Ren, N. Nakagawa, C. Xin, R. Newitt, S. Pandya, et al. 2015. Anti-microrna-21 oligonucleotides prevent alport nephropathy progression by stimulating metabolic pathways. The Journal of Clinical Investigation 125 (1):141–56. doi: 10.1172/jci75852.
   PubMed Web of Science ®Google Scholar
• Gong, Q., F. Li, J. Xie, and G. Su. 2019. Upregulated vegf and robo4 correlate with the reduction of mir-15a in the development of diabetic retinopathy. Endocrine 65 (1):35–45. doi: 10.1007/s12020-019-01921-0.
   PubMed Web of Science ®Google Scholar
• Gong, Q., J. Xie, Y. Liu, Y. Li, and G. Su. 2017. Differentially expressed micrornas in the development of early diabetic retinopathy. Journal of Diabetes Research 2017:4727942. doi: 10.1155/2017/4727942.
   PubMed Web of Science ®Google Scholar
• Guo, L., K. Tan, Q. Luo, and X. Bai. 2020. Dihydromyricetin promotes autophagy and attenuates renal interstitial fibrosis by regulating mir-155-5p/pten signaling in diabetic nephropathy. Bosnian Journal of Basic Medical Sciences 20 (3):372–80. doi: 10.17305/bjbms.2019.4410.
   PubMed Web of Science ®Google Scholar
• Guo, R, and S. Nair. 2017. Role of microrna in diabetic cardiomyopathy: from mechanism to intervention. Biochimica et Biophysica Acta. Molecular Basis of Disease 1863 (8):2070–7. doi: 10.1016/j.bbadis.2017.03.013.
   PubMed Web of Science ®Google Scholar
• Guo, S., J. Sun, and Y. Zhuang. 2020. Quercetin alleviates lipopolysaccharide-induced inflammatory responses by up-regulation mir-124 in human renal tubular epithelial cell line hk-2. BioFactors (Oxford, England) 46 (3):402–10. doi: 10.1002/biof.1596.
   PubMed Web of Science ®Google Scholar
• Han, F., J. Zhang, K. Li, W. Wang, and D. Dai. 2020. Triptolide protects human retinal pigment epithelial arpe-19 cells against high glucose-induced cell injury by regulation of mir-29b/pten. Archives of Physiology and Biochemistry 126:1–7. doi: 10.1080/13813455.2020.1797101.
   PubMedGoogle Scholar
• Han, N., W. Tian, N. Yu, and L. Yu. 2020. Yap1 is required for the angiogenesis in retinal microvascular endothelial cells via the inhibition of malat1‐mediated mir‐200b‐3p in high glucose‐induced diabetic retinopathy. Journal of Cellular Physiology 235 (2):1309–20. doi: 10.1002/jcp.29047.
   PubMed Web of Science ®Google Scholar
• Harada, M., X. Luo, T. Murohara, B. Yang, D. Dobrev, and S. Nattel. 2014. Microrna regulation and cardiac calcium signaling: role in cardiac disease and therapeutic potential. Circulation Research 114 (4):689–705. doi: 10.1161/CIRCRESAHA.114.301798.
   PubMed Web of Science ®Google Scholar
• Haviland, N., J. Walsh, R. Roberts, and T. S. Bailey. 2016. Update on clinical utility of continuous glucose monitoring in type 1 diabetes. Current Diabetes Reports 16 (11):115. doi: 10.1007/s11892-016-0808-5.
   PubMed Web of Science ®Google Scholar
• He, X., G. Kuang, Y. Zuo, S. Li, S. Zhou, and C. Ou. 2021. The role of non-coding rnas in diabetic nephropathy-related oxidative stress. Frontiers in Medicine 8:626423. doi: 10.3389/fmed.2021.626423.
   Web of Science ®Google Scholar
• Hou, Y., Y. Zhang, S. Lin, Y. Yu, L. Yang, L. Li, and W. Wang. 2021. Protective mechanism of apigenin in diabetic nephropathy is related to its regulation of mir-423-5p-usf2 axis. American Journal of Translational Research 13 (4):2006–20.
   PubMed Web of Science ®Google Scholar
• Hu, Q., C. Qu, X. Xiao, W. Zhang, Y. Jiang, Z. Wu, D. Song, X. Peng, X. Ma, and Y. Zhao. 2021. Flavonoids on diabetic nephropathy: advances and therapeutic opportunities. Chinese Medicine 16 (1):74. doi: 10.1186/s13020-021-00485-4.
   PubMed Web of Science ®Google Scholar
• Huang, D. D., G. Shi, Y. Jiang, C. Yao, and C. Zhu. 2020. A review on the potential of resveratrol in prevention and therapy of diabetes and diabetic complications. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 125:109767. doi: 10.1016/j.biopha.2019.109767.
   PubMed Web of Science ®Google Scholar
• Huang, J., J. Fu, B. Liu, R. Wang, and T. You. 2020. A synthetic curcuminoid analog, (2e,6e)-2,6-bis(2-(trifluoromethyl)benzylidene)cyclohexanone, ameliorates impaired wound healing in streptozotocin-induced diabetic mice by increasing mir-146a. Molecules (Basel, Switzerland) 25 (4):920. doi: 10.3390/molecules25040920.
   Web of Science ®Google Scholar
• Huang, S. S., D. F. Ding, S. Chen, C. L. Dong, X. L. Ye, Y. G. Yuan, Y. M. Feng, N. You, J. R. Xu, H. Miao, et al. 2017. Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy. Scientific Reports 7:45692. doi: 10.1038/srep45692.
   PubMed Web of Science ®Google Scholar
• Hui, Y, and Y. Yin. 2018. Microrna-145 attenuates high glucose-induced oxidative stress and inflammation in retinal endothelial cells through regulating tlr4/nf-κb signaling. Life Sciences 207:212–8. doi: 10.1016/j.lfs.2018.06.005.
   PubMed Web of Science ®Google Scholar
• Hur, J., K. A. Sullivan, M. Pande, Y. Hong, A. A. Sima, H. V. Jagadish, M. Kretzler, and E. L. Feldman. 2011. The identification of gene expression profiles associated with progression of human diabetic neuropathy. Brain 134 (11):3222–35. doi: 10.1093/brain/awr228.
   PubMedGoogle Scholar
• Hussain, G., S. A. A. Rizvi, S. Singhal, M. Zubair, and J. Ahmad. 2016. Serum levels of tgf-β1 in patients of diabetic peripheral neuropathy and its correlation with nerve conduction velocity in type 2 diabetes mellitus. Diabetes & Metabolic Syndrome 10 (1 Suppl 1):S135–S139. doi: 10.1016/j.dsx.2015.10.011.
   PubMedGoogle Scholar
• Ioannou, K. 2017. Diabetic nephropathy: is it always there? Assumptions, weaknesses and pitfalls in the diagnosis. Hormones (Athens, Greece) 16 (4):351–61.
   PubMedGoogle Scholar
• Jia, C., H. Chen, M. Wei, X. Chen, Y. Zhang, L. Cao, P. Yuan, F. Wang, G. Yang, and J. Ma. 2017. Gold nanoparticle-based mir155 antagonist macrophage delivery restores the cardiac function in ovariectomized diabetic mouse model. International Journal of Nanomedicine 12:4963–79. doi: 10.2147/ijn.s138400.
   PubMed Web of Science ®Google Scholar
• Jia, G., M. A. Hill, and J. R. Sowers. 2018. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circulation Research 122 (4):624–38. doi: 10.1161/circresaha.117.311586.
   PubMed Web of Science ®Google Scholar
• Jia, G., A. Whaley-Connell, and J. R. Sowers. 2018. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia 61 (1):21–8. doi: 10.1007/s00125-017-4390-4.
   PubMed Web of Science ®Google Scholar
• Jiang, Y., L. Liu, and J. J. Steinle. 2018. Mirna15a regulates insulin signal transduction in the retinal vasculature. Cellular Signalling 44:28–32. doi: 10.1016/j.cellsig.2018.01.016.
   PubMed Web of Science ®Google Scholar
• Kabir, M. T., N. Tabassum, M. S. Uddin, F. Aziz, T. Behl, B. Mathew, M. H. Rahman, R. Akter, A. Rauf, and L. Aleya. 2021. Therapeutic potential of polyphenols in the management of diabetic neuropathy. Evidence-Based Complementary and Alternative Medicine: eCAM 2021:9940169. doi: 10.1155/2021/9940169.
   PubMed Web of Science ®Google Scholar
• Khamaneh, A. M., M. R. Alipour, F. S. Hesari, and F. G. Soufi. 2015. A signature of microrna-155 in the pathogenesis of diabetic complications. Journal of Physiology and Biochemistry 71 (2):301–9. doi: 10.1007/s13105-015-0413-0.
   PubMed Web of Science ®Google Scholar
• Khanra, R., N. Bhattacharjee, T. K. Dua, A. Nandy, A. Saha, J. Kalita, P. Manna, and S. Dewanjee. 2017. Taraxerol, a pentacyclic triterpenoid, from abroma augusta leaf attenuates diabetic nephropathy in type 2 diabetic rats. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 94:726–41. doi: 10.1016/j.biopha.2017.07.112.
   PubMed Web of Science ®Google Scholar
• Khanra, R., S. Dewanjee, T. K. Dua, R. Sahu, M. Gangopadhyay, V. De Feo, and M. Zia-Ul-Haq. 2015. Abroma augusta L. (malvaceae) leaf extract attenuates diabetes induced nephropathy and cardiomyopathy via inhibition of oxidative stress and inflammatory response. Journal of Translational Medicine 13 (1):6–14. doi: 10.1186/s12967-014-0364-1.
   PubMedGoogle Scholar
• Khokhar, M., D. Roy, A. Modi, R. Agarwal, D. Yadav, P. Purohit, and P. Sharma. 2020. Perspectives on the role of pten in diabetic ­nephropathy: an update. Critical Reviews in Clinical Laboratory Sciences 57 (7):470–83. doi: 10.1080/10408363.2020.1746735.
   PubMed Web of Science ®Google Scholar
• Khursheed, R., S. K. Singh, S. Wadhwa, M. Gulati, B. Kapoor, A. Awasthi, A. Kr, R. Kumar, F. H. Pottoo, V. Kumar, et al. 2021. Opening eyes to therapeutic perspectives of bioactive polyphenols and their nanoformulations against diabetic neuropathy and related complications. Expert Opinion on Drug Delivery 18 (4):427–48. doi: 10.1080/17425247.2021.1846517.
   PubMed Web of Science ®Google Scholar
• Klimczak, D., M. Kuch, T. Pilecki, D. Żochowska, A. Wirkowska, and L. Pączek. 2017. Plasma microrna-155-5p is increased among patients with chronic kidney disease and nocturnal hypertension. Journal of the American Society of Hypertension: JASH 11 (12):831–41. doi: 10.1016/j.jash.2017.10.008.
   PubMed Web of Science ®Google Scholar
• Kolb, H, and S. Martin. 2017. Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes. BMC Medicine 15 (1):131. doi: 10.1186/s12916-017-0901-x.
   PubMedGoogle Scholar
• Kölling, M., T. Kaucsar, C. Schauerte, A. Hübner, A. Dettling, J. K. Park, M. Busch, X. Wulff, M. Meier, K. Scherf, et al. 2017. Therapeutic mir-21 silencing ameliorates diabetic kidney disease in mice. Molecular Therapy: The Journal of the American Society of Gene Therapy 25 (1):165–80. doi: 10.1016/j.ymthe.2016.08.001.
   PubMed Web of Science ®Google Scholar
• Kolset, S. O., F. P. Reinholt, and T. Jenssen. 2012. Diabetic nephropathy and extracellular matrix. The Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 60 (12):976–86. doi: 10.1369/0022155412465073.
   PubMed Web of Science ®Google Scholar
• Krichevsky, A. M, and G. Gabriely. 2009. Mir-21: a small multi-faceted RNA. Journal of Cellular and Molecular Medicine 13 (1):39–53. doi: 10.1111/j.1582-4934.2008.00556.x.
   PubMed Web of Science ®Google Scholar
• Kumar, A., G. Negi, and S. S. Sharma. 2013. Neuroprotection by resveratrol in diabetic neuropathy: concepts & mechanisms. Current Medicinal Chemistry 20 (36):4640–5. doi: 10.2174/09298673113209990151.
   PubMed Web of Science ®Google Scholar
• Kuwabara, Y., T. Horie, O. Baba, S. Watanabe, M. Nishiga, S. Usami, M. Izuhara, T. Nakao, T. Nishino, K. Otsu, et al. 2015. Microrna-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the lkb1/ampk pathway. Circulation Research 116 (2):279–88. doi: 10.1161/circresaha.116.304707.
   PubMed Web of Science ®Google Scholar
• Lai, J. Y., J. Luo, C. O’Connor, X. Jing, V. Nair, W. Ju, A. Randolph, I. Z. Ben-Dov, R. N. Matar, D. Briskin, et al. 2015. Microrna-21 in glomerular injury. Journal of the American Society of Nephrology 26 (4):805–16. doi: 10.1681/ASN.2013121274.
   PubMed Web of Science ®Google Scholar
• Latronico, M. V., L. Elia, G. Condorelli, and D. Catalucci. 2008. Heart failure: targeting transcriptional and post-transcriptional control mechanisms of hypertrophy for treatment. The International Journal of Biochemistry & Cell Biology 40 (9):1643–8. doi: 10.1016/j.biocel.2008.03.002.
   PubMed Web of Science ®Google Scholar
• Leinders, M., N. Üçeyler, A. Thomann, and C. Sommer. 2017. Aberrant microrna expression in patients with painful peripheral neuropathies. Journal of the Neurological Sciences 380:242–9. doi: 10.1016/j.jns.2017.07.041.
   PubMed Web of Science ®Google Scholar
• Li, D., Z. Lu, J. Jia, Z. Zheng, and S. Lin. 2013. Curcumin ameliorates podocytic adhesive capacity damage under mechanical stress by inhibiting mir-124 expression. Kidney & Blood Pressure Research 38 (1):61–71. doi: 10.1159/000355755.
   PubMed Web of Science ®Google Scholar
• Li, D., Z. Lu, J. Jia, Z. Zheng, and S. Lin. 2013. Mir-124 is related to podocytic adhesive capacity damage in stz-induced uninephrectomized diabetic rats. Kidney & Blood Pressure Research 37 (4-5):422–31. doi: 10.1159/000355721.
   PubMed Web of Science ®Google Scholar
• Li, H., M. W. Liu, W. Yang, L. J. Wan, H. L. Yan, J. C. Li, S. Y. Tang, and Y. Q. Wang. 2020. Naringenin induces neuroprotection against homocysteine-induced pc12 cells via the upregulation of superoxide dismutase 1 expression by decreasing mir-224-3p expression. Journal of Biological Regulators and Homeostatic Agents 34 (2):421–33. doi: 10.23812/20-27-a-39.
   PubMed Web of Science ®Google Scholar
• Li, S. H., M. S. Wang, W. L. Ke, and M. R. Wang. 2021. Naringenin alleviates myocardial ischemia reperfusion injury by enhancing the myocardial mir-126-pi3k/akt axis in streptozotocin-induced diabetic rats. Experimental and Therapeutic Medicine 22 (2):810. doi: 10.3892/etm.2021.10242.
   PubMed Web of Science ®Google Scholar
• Li, X., N. Du, Q. Zhang, J. Li, X. Chen, X. Liu, Y. Hu, W. Qin, N. Shen, C. Xu, et al. 2014. Microrna-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy. Cell Death & Disease 5 (10):e1479-e1479. doi: 10.1038/cddis.2014.430.
   Google Scholar
• Li, X. Y., Y. Q. Zhang, G. Xu, S. H. Li, and H. Li. 2018. Mir-124/mcp-1 signaling pathway modulates the protective effect of itraconazole on acute kidney injury in a mouse model of disseminated candidiasis. International Journal of Molecular Medicine 41 (6):3468–76. doi: 10.3892/ijmm.2018.3564.
   PubMed Web of Science ®Google Scholar
• Li, Y., S. Zhao, L. V. der Merwe, W. Dai, and C. Lin. 2022. Efficacy of curcumin for wound repair in diabetic rats/mice: a systematic review and meta-analysis of preclinical studies. Current Pharmaceutical Design 28DOI (3):187–97. doi: 10.2174/1381612827666210617122026.
   PubMed Web of Science ®Google Scholar
• Liu, K., F. Mei, Y. Wang, N. Xiao, L. Yang, Y. Wang, J. Li, F. Huang, J. Kou, B. Liu, et al. 2016. Quercetin oppositely regulates insulin-mediated glucose disposal in skeletal muscle under normal and inflammatory conditions: the dual roles of ampk activation. Molecular Nutrition & Food Research 60 (3):551–65. doi: 10.1002/mnfr.201500509.
   PubMed Web of Science ®Google Scholar
• Liu, L., Y. Wang, R. Yan, L. Liang, X. Zhou, H. Liu, X. Zhang, Y. Mao, W. Peng, Y. Xiao, et al. 2019. Bmp-7 inhibits renal fibrosis in diabetic nephropathy via mir-21 downregulation. Life Sciences 238:116957. doi: 10.1016/j.lfs.2019.116957.
   PubMed Web of Science ®Google Scholar
• Liu, W., Q. Ao, Q. Guo, W. He, L. Peng, J. Jiang, and X. Hu. 2017. Mir-9 mediates calhm1-activated atp-p2x7r signal in painful diabetic neuropathy rats. Molecular Neurobiology 54 (2):922–9. doi: 10.1007/s12035-016-9700-1.
   PubMed Web of Science ®Google Scholar
• Liu, X. S., B. Fan, A. Szalad, L. Jia, L. Wang, X. Wang, W. Pan, L. Zhang, R. Zhang, J. Hu, et al. 2017. Microrna-146a mimics reduce the peripheral neuropathy in type 2 diabetic mice. Diabetes 66 (12):3111–21. doi: 10.2337/db16-1182.
   PubMed Web of Science ®Google Scholar
• Liu, Y., G. Gao, C. Yang, K. Zhou, B. Shen, H. Liang, and X. Jiang. 2014. The role of circulating microrna-126 (mir-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus. International Journal of Molecular Sciences 15 (6):10567–77. doi: 10.3390/ijms150610567.
   PubMed Web of Science ®Google Scholar
• Liu, Y., Y. Wang, X. Miao, S. Zhou, Y. Tan, G. Liang, Y. Zheng, Q. Liu, J. Sun, and L. Cai. 2014. Inhibition of jnk by compound c66 prevents pathological changes of the aorta in stz-induced diabetes. Journal of Cellular and Molecular Medicine 18 (6):1203–12. doi: 10.1111/jcmm.12267.
   PubMed Web of Science ®Google Scholar
• Liu, Y., J. Xiao, Y. Zhao, C. Zhao, Q. Yang, X. Du, and X. Wang. 2020. Microrna-216a protects against human retinal microvascular endothelial cell injury in diabetic retinopathy by suppressing the nos2/jak/stat axis. Experimental and Molecular Pathology 115:104445. doi: 10.1016/j.yexmp.2020.104445.
   PubMed Web of Science ®Google Scholar
• Loeffler, I, and G. Wolf. 2015. Epithelial-to-mesenchymal transition in diabetic nephropathy: fact or fiction? Cells 4 (4):631–52. doi: 10.3390/cells4040631.
   PubMed Web of Science ®Google Scholar
• Lorenzo-Almorós, A., J. M. Cepeda-Rodrigo, and Ó. Lorenzo. 2020. Diabetic cardiomyopathy. Revista Clinica Espanola 124 (8):1160–62. doi: 10.1016/j.rce.2019.10.013.
   Google Scholar
• Lou, Z., Q. Li, C. Wang, and Y. Li. 2020. The effects of microrna-126 reduced inflammation and apoptosis of diabetic nephropathy through pi3k/akt signalling pathway by vegf. Archives of Physiology and Biochemistry 216:1–10. doi: 10.1080/13813455.2020.1767146.
   Google Scholar
• Ma, S., L. Fan, J. Li, B. Zhang, and Z. Yan. 2020. Resveratrol promoted the m2 polarization of microglia and reduced neuroinflammation after cerebral ischemia by inhibiting mir-155. The International Journal of Neuroscience 130 (8):817–25. doi: 10.1080/00207454.2019.1707817.
   PubMed Web of Science ®Google Scholar
• Madhyastha, R., H. Madhyastha, Y. Nakajima, S. Omura, and M. Maruyama. 2012. Microrna signature in diabetic wound healing: promotive role of mir-21 in fibroblast migration. International Wound Journal 9 (4):355–61. doi: 10.1111/j.1742-481X.2011.00890.x.
   PubMed Web of Science ®Google Scholar
• Malik, S., K. Suchal, S. I. Khan, J. Bhatia, K. Kishore, A. K. Dinda, and D. S. Arya. 2017. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via mapk-nf-κb-tnf-α and tgf-β1-mapk-fibronectin pathways. American Journal of Physiology. Renal Physiology 313 (2):F414–f422. doi: 10.1152/ajprenal.00393.2016.
   PubMed Web of Science ®Google Scholar
• Mastropasqua, R., R. D’Aloisio, E. Costantini, A. Porreca, G. Ferro, D. Libertini, M. Reale, M. Di Nicola, P. Viggiano, G. Falconio, et al. 2021. Serum microrna levels in diabetes mellitus. Diagnostics 11 (2):284. doi: 10.3390/diagnostics11020284.
   Web of Science ®Google Scholar
• Matos, A. L., D. F. Bruno, A. F. Ambrósio, and P. F. Santos. 2020. The benefits of flavonoids in diabetic retinopathy. Nutrients 12 (10):3169. doi: 10.3390/nu12103169.
   PubMed Web of Science ®Google Scholar
• Matsushima, S, and J. Sadoshima. 2015. The role of sirtuins in cardiac disease. American Journal of Physiology. Heart and Circulatory Physiology 309 (9):H1375–1389. doi: 10.1152/ajpheart.00053.2015.
   PubMed Web of Science ®Google Scholar
• McClelland, A. D, and P. Kantharidis. 2014. Microrna in the development of diabetic complications. Clinical Science (London, England: 1979) 126 (2):95–110. doi: 10.1042/cs20130079.
   PubMed Web of Science ®Google Scholar
• Melman, Y. F., R. Shah, and S. Das. 2014. Micrornas in heart failure: is the picture becoming less mirky? Circulation. Heart Failure 7 (1):203–14. doi: 10.1161/CIRCHEARTFAILURE.113.000266.
   PubMed Web of Science ®Google Scholar
• Meng, J. M., S. Y. Cao, X. L. Wei, R. Y. Gan, Y. F. Wang, S. X. Cai, X. Y. Xu, P. Z. Zhang, and H. B. Li. 2019. Effects and mechanisms of tea for the prevention and management of diabetes mellitus and diabetic complications: an updated review. Antioxidants (Basel, Switzerland) 8 (6):170. doi: 10.3390/antiox8060170.
   PubMedGoogle Scholar
• Meng, S., J. T. Cao, B. Zhang, Q. Zhou, C. X. Shen, and C. Q. Wang. 2012. Downregulation of microrna-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene spred-1. Journal of Molecular and Cellular Cardiology 53 (1):64–72. doi: 10.1016/j.yjmcc.2012.04.003.
   PubMed Web of Science ®Google Scholar
• Mokhtari, M., R. Razzaghi, and M. Momen-Heravi. 2021. The effects of curcumin intake on wound healing and metabolic status in patients with diabetic foot ulcer: a randomized, double-blind, placebo-controlled trial. Phytotherapy Research 35 (4):2099–107. doi: 10.1002/ptr.6957.
   PubMed Web of Science ®Google Scholar
• Ni, T., N. Lin, W. Lu, Z. Sun, H. Lin, J. Chi, and H. Guo. 2020. Dihydromyricetin prevents diabetic cardiomyopathy via mir-34a suppression by activating autophagy. Cardiovascular Drugs and Therapy 34 (3):291–301. doi: 10.1007/s10557-020-06968-0.
   PubMed Web of Science ®Google Scholar
• Orhan, I. E., S. F. Nabavi, M. Daglia, G. C. Tenore, K. Mansouri, and S. M. Nabavi. 2015. Naringenin and atherosclerosis: a review of literature. Current Pharmaceutical Biotechnology 16 (3):245–51. doi: 10.2174/1389201015666141202110216.
   PubMed Web of Science ®Google Scholar
• Ozdemir, D, and M. W. Feinberg. 2019. Micrornas in diabetic wound healing: pathophysiology and therapeutic opportunities. Trends in Cardiovascular Medicine 29 (3):131–7. doi: 10.1016/j.tcm.2018.08.002.
   PubMed Web of Science ®Google Scholar
• Pan, L., K. S. Cho, I. Yi, C. H. To, D. F. Chen, and C. W. Do. 2021. Baicalein, baicalin, and wogonin: protective effects against ischemia-induced neurodegeneration in the brain and retina. Oxidative Medicine and Cellular Longevity 2021:8377362. doi: 10.1155/2021/8377362.
   PubMed Web of Science ®Google Scholar
• Pan, Y., X. Zhang, Y. Wang, L. Cai, L. Ren, L. Tang, J. Wang, Y. Zhao, Y. Wang, Q. Liu, et al. 2013. Targeting jnk by a new curcumin analog to inhibit nf-kb-mediated expression of cell adhesion molecules attenuates renal macrophage infiltration and injury in diabetic mice. PloS One 8 (11):e79084. doi: 10.1371/journal.pone.0079084.
   PubMed Web of Science ®Google Scholar
• Park, S., S. Moon, K. Lee, I. B. Park, D. H. Lee, and S. Nam. 2018. Urinary and blood microrna-126 and -770 are potential noninvasive biomarker candidates for diabetic nephropathy: a meta-analysis. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology 46 (4):1331–40. doi: 10.1159/000489148.
   PubMedGoogle Scholar
• Petkovic, M., A. E. Sørensen, E. C. Leal, E. Carvalho, and L. T. Dalgaard. 2020. Mechanistic actions of micrornas in diabetic wound healing. Cells 9 (10):2228. doi: 10.3390/cells9102228.
   Web of Science ®Google Scholar
• Platania, C. B. M., R. Maisto, M. C. Trotta, M. D'Amico, S. Rossi, C. Gesualdo, G. D'Amico, C. Balta, H. Herman, A. Hermenean, et al. 2019. Retinal and circulating mirna expression patterns in diabetic retinopathy: an in silico and in vivo approach. British Journal of Pharmacology 176 (13):2179–94. doi: 10.1111/bph.14665.
   PubMed Web of Science ®Google Scholar
• Podgórski, P., A. Konieczny, Ł. Lis, W. Witkiewicz, and Z. Hruby. 2019. Glomerular podocytes in diabetic renal disease. Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University 28 (12):1711–5. doi: 10.17219/acem/104534.
   PubMed Web of Science ®Google Scholar
• Pop-Busui, R., L. Ang, C. Holmes, K. Gallagher, and E. L. Feldman. 2016. Inflammation as a therapeutic target for diabetic neuropathies. Current Diabetes Reports 16 (3):29. doi: 10.1007/s11892-016-0727-5.
   PubMed Web of Science ®Google Scholar
• Qihui, L., D. Shuntian, Z. Xin, Y. Xiaoxia, and C. Zhongpei. 2020. Protection of curcumin against streptozocin-induced pancreatic cell destruction in t2d rats. Planta Medica 86 (2):113–20. doi: 10.1055/a-1046-1404.
   PubMed Web of Science ®Google Scholar
• Rahigude, A., P. Bhutada, S. Kaulaskar, M. Aswar, and K. Otari. 2012. Participation of antioxidant and cholinergic system in protective effect of naringenin against type-2 diabetes-induced memory dysfunction in rats. Neuroscience 226:62–72. doi: 10.1016/j.neuroscience.2012.09.026.
   PubMed Web of Science ®Google Scholar
• Rao, P. K., Y. Toyama, H. R. Chiang, S. Gupta, M. Bauer, R. Medvid, F. Reinhardt, R. Liao, M. Krieger, R. Jaenisch, et al. 2009. Loss of cardiac microrna-mediated regulation leads to dilated cardiomyopathy and heart failure. Circulation Research 105 (6):585–94. doi: 10.1161/CIRCRESAHA.109.200451.
   PubMed Web of Science ®Google Scholar
• Raut, S. K., G. B. Singh, B. Rastogi, U. N. Saikia, A. Mittal, N. Dogra, S. Singh, R. Prasad, and M. Khullar. 2016. Mir-30c and mir-181a synergistically modulate p53-p21 pathway in diabetes induced cardiac hypertrophy. Molecular and Cellular Biochemistry 417 (1-2):191–203. doi: 10.1007/s11010-016-2729-7.
   PubMed Web of Science ®Google Scholar
• Regazzi, R. 2018. Micrornas as therapeutic targets for the treatment of diabetes mellitus and its complications. Expert Opinion on Therapeutic Targets 22 (2):153–60. doi: 10.1080/14728222.2018.1420168.
   PubMed Web of Science ®Google Scholar
• Rizzo, M. R., R. Marfella, M. Barbieri, V. Boccardi, F. Vestini, B. Lettieri, S. Canonico, and G. Paolisso. 2010. Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients. Diabetes Care 33 (10):2169–74. doi: 10.2337/dc10-0389.
   PubMed Web of Science ®Google Scholar
• Roy, D., A. Modi, M. Khokhar, S. Sankanagoudar, D. Yadav, S. Sharma, P. Purohit, and P. Sharma. 2021. Microrna 21 emerging role in diabetic complications: a critical update. Current Diabetes Reviews 17 (2):122–35. doi: 10.2174/1573399816666200503035035.
   PubMed Web of Science ®Google Scholar
• Rubler, S., J. Dlugash, Y. Z. Yuceoglu, T. Kumral, A. W. Branwood, and A. Grishman. 1972. New type of cardiomyopathy associated with diabetic glomerulosclerosis. The American Journal of Cardiology 30 (6):595–602. doi: 10.1016/0002-9149(72)90595-4.
   PubMed Web of Science ®Google Scholar
• Samsu, N. 2021. Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment. BioMed Research International 2021:1–17. doi: 10.1155/2021/1497449.
   PubMed Web of Science ®Google Scholar
• Sanders, J. L, and A. B. Newman. 2013. Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither? Epidemiologic Reviews 35 (1):112–31. doi: 10.1093/epirev/mxs008.
   PubMed Web of Science ®Google Scholar
• Shao, Y., C. Lv, C. Wu, Y. Zhou, and Q. Wang. 2016. Mir-217 promotes inflammation and fibrosis in high glucose cultured rat glomerular mesangial cells via sirt1/hif-1α signaling pathway. Diabetes/Metabolism Research and Reviews 32 (6):534–43. doi: 10.1002/dmrr.2788.
   PubMed Web of Science ®Google Scholar
• Shishodia, S., H. M. Amin, R. Lai, and B. B. Aggarwal. 2005. Curcumin (diferuloylmethane) inhibits constitutive nf-kappab activation, induces g1/s arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochemical Pharmacology 70 (5):700–13. doi: 10.1016/j.bcp.2005.04.043.
   PubMed Web of Science ®Google Scholar
• Simeoli, R, and A. Fierabracci. 2019. Insights into the role of micrornas in the onset and development of diabetic neuropathy. International Journal of Molecular Sciences 20 (18):4627. doi: 10.3390/ijms20184627.
   PubMed Web of Science ®Google Scholar
• Simpson, K., A. Wonnacott, D. J. Fraser, and T. Bowen. 2016. Micrornas in diabetic nephropathy: from biomarkers to therapy. Current Diabetes Reports 16 (3):35. doi: 10.1007/s11892-016-0724-8.
   PubMed Web of Science ®Google Scholar
• Singh, P., S. Bansal, A. Kuhad, A. Kumar, and K. Chopra. 2020. Naringenin ameliorates diabetic neuropathic pain by modulation of oxidative-nitrosative stress, cytokines and mmp-9 levels. Food & Function 11 (5):4548–60. doi: 10.1039/c9fo00881k.
   PubMed Web of Science ®Google Scholar
• Smit-McBride, Z, and L. S. Morse. 2021. Microrna and diabetic retinopathy—biomarkers and novel therapeutics. Annals of Translational Medicine 9 (15):1280– doi: 10.21037/atm-20-5189.
   PubMed Web of Science ®Google Scholar
• Su, H. C., L. M. Hung, and J. K. Chen. 2006. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. American Journal of Physiology. Endocrinology and Metabolism 290 (6):E1339–1346. doi: 10.1152/ajpendo.00487.2005.
   PubMed Web of Science ®Google Scholar
• Sulaiman, M., M. J. Matta, N. R. Sunderesan, M. P. Gupta, M. Periasamy, and M. Gupta. 2010. Resveratrol, an activator of sirt1, upregulates sarcoplasmic calcium atpase and improves cardiac function in diabetic cardiomyopathy. American Journal of Physiology. Heart and Circulatory Physiology 298 (3):H833–843. doi: 10.1152/ajpheart.00418.2009.
   PubMed Web of Science ®Google Scholar
• Sun, Q., J. Zeng, Y. Liu, J. Chen, Q. C. Zeng, Y. Q. Chen, L. L. Tu, P. Chen, F. Yang, and M. Zhang. 2020. Microrna-9 and -29a regulate the progression of diabetic peripheral neuropathy via isl1-mediated sonic hedgehog signaling pathway. Aging 12 (12):11446–65. doi: 10.18632/aging.103230.
   PubMedGoogle Scholar
• Sundaresan, N. R., V. B. Pillai, and M. P. Gupta. 2011. Emerging roles of sirt1 deacetylase in regulating cardiomyocyte survival and hypertrophy. Journal of Molecular and Cellular Cardiology 51 (4):614–8. doi: 10.1016/j.yjmcc.2011.01.008.
   PubMed Web of Science ®Google Scholar
• SunYM, S. 2013. Recentadvancesinunderstandingthe biochemicalandmolecularmechanism ofdiabeticnephropathy. Biochemical & Biophysical Research Communications 433 (4):359G361.
   Google Scholar
• Takiyama, Y., T. Harumi, J. Watanabe, Y. Fujita, J. Honjo, N. Shimizu, Y. Makino, and M. Haneda. 2011. Tubular injury in a rat model of type 2 diabetes is prevented by metformin: a possible role of hif-1α expression and oxygen metabolism. Diabetes 60 (3):981–92. doi: 10.2337/db10-0655.
   PubMed Web of Science ®Google Scholar
• Tang, L., K. Li, Y. Zhang, H. Li, A. Li, Y. Xu, and B. Wei. 2020. Quercetin liposomes ameliorate streptozotocin-induced diabetic nephropathy in diabetic rats. Scientific Reports 10 (1):2440. doi: 10.1038/s41598-020-59411-7.
   PubMed Web of Science ®Google Scholar
• Tiboni, M., S. Coppari, L. Casettari, M. Guescini, M. Colomba, D. Fraternale, A. Gorassini, G. Verardo, S. Ramakrishna, L. Guidi, et al. 2020. Prunus spinosa extract loaded in biomimetic nanoparticles evokes in vitro anti-inflammatory and wound healing activities. Nanomaterials (Basel, Switzerland) 11 (1):36. doi: 10.3390/nano11010036.
   Google Scholar
• Tili, E., J. J. Michaille, B. Adair, H. Alder, E. Limagne, C. Taccioli, M. Ferracin, D. Delmas, N. Latruffe, and C. M. Croce. 2010. Resveratrol decreases the levels of mir-155 by upregulating mir-663, a microrna targeting junb and jund. Carcinogenesis 31 (9):1561–6. doi: 10.1093/carcin/bgq143.
   PubMed Web of Science ®Google Scholar
• Tomé-Carneiro, J., M. Larrosa, M. J. Yáñez-Gascón, A. Dávalos, J. Gil-Zamorano, M. Gonzálvez, F. J. García-Almagro, J. A. Ruiz Ros, F. A. Tomás-Barberán, J. C. Espín, et al. 2013. One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related micrornas and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. Pharmacological Research 72:69–82. doi: 10.1016/j.phrs.2013.03.011.
   PubMed Web of Science ®Google Scholar
• Tuttolomondo, A., C. Maida, and A. Pinto. 2015. Diabetic foot syndrome as a possible cardiovascular marker in diabetic patients. Journal of Diabetes Research 2015:268390. doi: 10.1155/2015/268390.
   PubMed Web of Science ®Google Scholar
• ValdezGuerrero, A. S., J. C. Quintana-Pérez, M. G. Arellano-Mendoza, F. J. Castañeda-Ibarra, F. Tamay-Cach, and D. Alemán-González-Duhart. 2021. Diabetic retinopathy: important biochemical alterations and the main treatment strategies. Canadian Journal of Diabetes 45 (6):504–11. doi: 10.1016/j.jcjd.2020.10.009.
   PubMed Web of Science ®Google Scholar
• Venkat, P., C. Cui, M. Chopp, A. Zacharek, F. Wang, J. Landschoot-Ward, Y. Shen, and J. Chen. 2019. Mir-126 mediates brain endothelial cell exosome treatment-induced neurorestorative effects after stroke in type 2 diabetes mellitus mice. Stroke 50 (10):2865–74. doi: 10.1161/strokeaha.119.025371.
   PubMed Web of Science ®Google Scholar
• Verzola, D., M. T. Gandolfo, G. Gaetani, A. Ferraris, R. Mangerini, F. Ferrario, B. Villaggio, F. Gianiorio, F. Tosetti, U. Weiss, et al. 2008. Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy. American Journal of Physiology-Renal Physiology 295 (5):F1563–F1573. doi: 10.1152/ajprenal.90302.2008.
   PubMed Web of Science ®Google Scholar
• Viard, P., A. J. Butcher, G. Halet, A. Davies, B. Nürnberg, F. Heblich, and A. C. Dolphin. 2004. Pi3k promotes voltage-dependent calcium channel trafficking to the plasma membrane. Nature Neuroscience 7 (9):939–46. doi: 10.1038/nn1300.
   PubMed Web of Science ®Google Scholar
• Wang, J., L. Duan, L. Tian, J. Liu, S. Wang, Y. Gao, and J. Yang. 2016. Serum mir-21 may be a potential diagnostic biomarker for diabetic nephropathy. Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association 124 (7):417–23. doi: 10.1055/s-0035-1565095.
   PubMed Web of Science ®Google Scholar
• Wang, L., M. Chopp, A. Szalad, Y. Zhang, X. Wang, R. L. Zhang, X. S. Liu, L. Jia, and Z. G. Zhang. 2014. The role of mir-146a in dorsal root ganglia neurons of experimental diabetic peripheral neuropathy. Neuroscience 259:155–63. doi: 10.1016/j.neuroscience.2013.11.057.
   PubMed Web of Science ®Google Scholar
• Wang, Q., S. Navitskaya, H. Chakravarthy, C. Huang, N. Kady, T. A. Lydic, Y. E. Chen, K. J. Yin, F. L. Powell, P. M. Martin, et al. 2016. Dual anti-inflammatory and anti-angiogenic action of mir-15a in diabetic retinopathy. EBioMedicine 11:138–50. doi: 10.1016/j.ebiom.2016.08.013.
   PubMed Web of Science ®Google Scholar
• Wang, W., Y. Zheng, M. Wang, M. Yan, J. Jiang, and Z. Li. 2019. Exosomes derived mir-126 attenuates oxidative stress and apoptosis from ischemia and reperfusion injury by targeting errfi1. Gene 690:75–80. doi: 10.1016/j.gene.2018.12.044.
   PubMed Web of Science ®Google Scholar
• Wang, X., H. Li, H. Wang, and J. Shi. 2020. Quercetin attenuates high glucose-induced injury in human retinal pigment epithelial cell line arpe-19 by up-regulation of mir-29b. Journal of Biochemistry 167 (5):495–502. doi: 10.1093/jb/mvaa001.
   PubMed Web of Science ®Google Scholar
• Wang, Y., A. M. Schmeichel, H. Iida, J. D. Schmelzer, and P. A. Low. 2006. Enhanced inflammatory response via activation of nf-κb in acute experimental diabetic neuropathy subjected to ischemia–reperfusion injury. Journal of the Neurological Sciences 247 (1):47–52. doi: 10.1016/j.jns.2006.03.011.
   PubMed Web of Science ®Google Scholar
• Wong, T. Y., C. M. Cheung, M. Larsen, S. Sharma, and R. Simó. 2016. Diabetic retinopathy. Nature Reviews. Disease Primers 2:16012. doi: 10.1038/nrdp.2016.12.
   PubMed Web of Science ®Google Scholar
• Wu, B., J. Lin, J. Luo, D. Han, M. Fan, T. Guo, L. Tao, M. Yuan, and F. Yi. 2017. Dihydromyricetin protects against diabetic cardiomyopathy in streptozotocin-induced diabetic mice. BioMed Research International 2017:3764370. doi: 10.1155/2017/3764370.
   PubMed Web of Science ®Google Scholar
• Wu, D., N. Luo, L. Wang, Z. Zhao, H. Bu, G. Xu, Y. Yan, X. Che, Z. Jiao, T. Zhao, et al. 2017. Hydrogen sulfide ameliorates chronic renal failure in rats by inhibiting apoptosis and inflammation through ros/mapk and nf-κb signaling pathways. Scientific Reports 7 (1):455. doi: 10.1038/s41598-017-00557-2.
   PubMedGoogle Scholar
• Wu, H., L. Kong, Y. Tan, P. N. Epstein, J. Zeng, J. Gu, G. Liang, M. Kong, X. Chen, L. Miao, et al. 2016. C66 ameliorates diabetic nephropathy in mice by both upregulating nrf2 function via increase in mir-200a and inhibiting mir-21. Diabetologia 59 (7):1558–68. doi: 10.1007/s00125-016-3958-8.
   PubMed Web of Science ®Google Scholar
• Wu, H., L. Kong, S. Zhou, W. Cui, F. Xu, M. Luo, X. Li, Y. Tan, and L. Miao. 2014. The role of micrornas in diabetic nephropathy. Journal of Diabetes Research 2014:920134. doi: 10.1155/2014/920134.
   PubMed Web of Science ®Google Scholar
• Wu, L., Q. Wang, F. Guo, X. Ma, J. Wang, Y. Zhao, Y. Yan, and G. Qin. 2021. Involvement of mir-27a-3p in diabetic nephropathy via affecting renal fibrosis, mitochondrial dysfunction, and endoplasmic reticulum stress. Journal of Cellular Physiology 236 (2):1454–68. doi: 10.1002/jcp.29951.
   PubMed Web of Science ®Google Scholar
• Xiao, J. R., C. W. Do, and C. H. To. 2014. Potential therapeutic effects of baicalein, baicalin, and wogonin in ocular disorders. Journal of Ocular Pharmacology and Therapeutics: The Official Journal of the Association for Ocular Pharmacology and Therapeutics 30 (8):605–14. doi: 10.1089/jop.2014.0074.
   PubMed Web of Science ®Google Scholar
• Xin, Y., H. Zhang, Z. Jia, X. Ding, Y. Sun, Q. Wang, and T. Xu. 2018. Resveratrol improves uric acid-induced pancreatic β-cells injury and dysfunction through regulation of mir-126. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 102:1120–6. doi: 10.1016/j.biopha.2018.03.172.
   PubMed Web of Science ®Google Scholar
• Xu, J., W. Wu, L. Zhang, W. Dorset-Martin, M. W. Morris, M. E. Mitchell, and K. W. Liechty. 2012. The role of microrna-146a in the pathogenesis of the diabetic wound-healing impairment: correction with mesenchymal stem cell treatment. Diabetes 61 (11):2906–12. doi: 10.2337/db12-0145.
   PubMed Web of Science ®Google Scholar
• Xu, X. H., D. F. Ding, H. J. Yong, C. L. Dong, N. You, X. L. Ye, M. L. Pan, J. H. Ma, Q. You, and Y. B. Lu. 2017. Resveratrol transcriptionally regulates mirna-18a-5p expression ameliorating diabetic nephropathy via increasing autophagy. European Review for Medical and Pharmacological Sciences 21 (21):4952–65.
   PubMed Web of Science ®Google Scholar
• Yan, N., L. Wen, R. Peng, H. Li, H. Liu, H. Peng, Y. Sun, T. Wu, L. Chen, Q. Duan, et al. 2016. Naringenin ameliorated kidney injury through let-7a/tgfbr1 signaling in diabetic nephropathy. Journal of Diabetes Research 2016:8738760. doi: 10.1155/2016/8738760.
   PubMed Web of Science ®Google Scholar
• Yang, B., S. Ma, Y. B. Wang, B. Xu, H. Zhao, Y. Y. He, C. W. Li, J. Zhang, Y. K. Cao, and Q. Z. Feng. 2016. Resveratrol exerts protective effects on anoxia/reoxygenation injury in cardiomyocytes via mir-34a/sirt1 signaling pathway. European Review for Medical and Pharmacological Sciences 20 (12):2734–41.
   PubMed Web of Science ®Google Scholar
• Yang, J., X. Miao, F. J. Yang, J. F. Cao, X. Liu, J. L. Fu, and G. F. Su. 2021. Therapeutic potential of curcumin in diabetic retinopathy (review). International Journal of Molecular Medicine 47 (5):312–9. doi: 10.3892/ijmm.2021.4908.
   Web of Science ®Google Scholar
• Yang, Y., H. W. Cheng, Y. Qiu, D. Dupee, M. Noonan, Y. D. Lin, S. Fisch, K. Unno, K. I. Sereti, and R. Liao. 2015. Microrna-34a plays a key role in cardiac repair and regeneration following myocardial infarction. Circulation Research 117 (5):450–9. doi: 10.1161/circresaha.117.305962.
   PubMed Web of Science ®Google Scholar
• Yarahmadi, A., S. Z. Shahrokhi, Z. Mostafavi-Pour, and N. Azarpira. 2021. Micrornas in diabetic nephropathy: from molecular mechanisms to new therapeutic targets of treatment. Biochemical Pharmacology 189:114301. doi: 10.1016/j.bcp.2020.114301.
   PubMed Web of Science ®Google Scholar
• Yin, Z., Y. Zhao, M. He, H. Li, J. Fan, X. Nie, M. Yan, C. Chen, and D. W. Wang. 2019. Mir-30c/pgc-1β protects against diabetic cardiomyopathy via pparα. Cardiovascular Diabetology 18 (1):7. doi: 10.1186/s12933-019-0811-7.
   PubMedGoogle Scholar
• Yoshida-Hata, N., Y. Mitamura, T. Oshitari, K. Namekata, C. Harada, T. Harada, and S. Yamamoto. 2010. Transcription factor, sp1, in epiretinal membranes of patients with proliferative diabetic retinopathy. Diabetes Research and Clinical Practice 87 (3):e26–8. doi: 10.1016/j.diabres.2009.12.008.
   PubMedGoogle Scholar
• Yu, Y., F. Bai, N. Qin, W. Liu, Q. Sun, Y. Zhou, and J. Yang. 2018. Non-proximal renal tubule-derived urinary exosomal mir-200b as a biomarker of renal fibrosis. Nephron 139 (3):269–82. doi: 10.1159/000487104.
   PubMed Web of Science ®Google Scholar
• Zaidun, N. H., Z. C. Thent, and A. A. Latiff. 2018. Combating oxidative stress disorders with citrus flavonoid: naringenin. Life Sciences 208:111–22. doi: 10.1016/j.lfs.2018.07.017.
   PubMed Web of Science ®Google Scholar
• Zakin, E., R. Abrams, and D. M. Simpson. 2019. Diabetic neuropathy. Seminars in Neurology 39 (5):560–9. doi: 10.1055/s-0039-1688978.
   PubMed Web of Science ®Google Scholar
• Zarjou, A., S. Yang, E. Abraham, A. Agarwal, and G. Liu. 2011. Identification of a microrna signature in renal fibrosis: role of mir-21. American Journal of Physiology. Renal Physiology 301 (4):F793–801. doi: 10.1152/ajprenal.00273.2011.
   PubMed Web of Science ®Google Scholar
• Zeng, K., Y. Wang, N. Yang, D. Wang, S. Li, J. Ming, J. Wang, X. Yu, Y. Song, X. Zhou, et al. 2017. Resveratrol inhibits diabetic-induced müller cells apoptosis through microrna-29b/specificity protein 1 pathway. Molecular Neurobiology 54 (6):4000–14. doi: 10.1007/s12035-016-9972-5.
   PubMed Web of Science ®Google Scholar
• Zeng, Y., Z. Cui, J. Liu, J. Chen, and S. Tang. 2019. Microrna-29b-3p promotes human retinal microvascular endothelial cell apoptosis via blocking sirt1 in diabetic retinopathy. Frontiers in Physiology 10:1621. doi: 10.3389/fphys.2019.01621.
   PubMed Web of Science ®Google Scholar
• Zhang, F., K. Wang, F. Gao, Y. Xuan, X. Liu, and Z. Zhang. 2021. Resveratrol pretreatment improved heart recovery ability of hyperglycemic bone marrow stem cells transplantation in diabetic myocardial infarction by down-regulating microrna-34a. Frontiers in Pharmacology 12:632375. doi: 10.3389/fphar.2021.632375.
   PubMed Web of Science ®Google Scholar
• Zhang, J., Y. Chen, H. Luo, L. Sun, M. Xu, J. Yu, Q. Zhou, G. Meng, and S. Yang. 2018. Recent update on the pharmacological effects and mechanisms of dihydromyricetin. Frontiers in Pharmacology 9:1204. doi: 10.3389/fphar.2018.01204.
   PubMed Web of Science ®Google Scholar
• Zhang, J., H. Fu, Y. Xu, Y. Niu, and X. An. 2016. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury. Journal of Natural Medicines 70 (4):740–8. doi: 10.1007/s11418-016-1007-z.
   PubMed Web of Science ®Google Scholar
• Zhang, J., L. Wu, J. Chen, S. Lin, D. Cai, C. Chen, and Z. Chen. 2018. Downregulation of microrna 29a/b exacerbated diabetic retinopathy by impairing the function of müller cells via forkhead box protein o4. Diabetes & Vascular Disease Research 15 (3):214–22. doi: 10.1177/1479164118756239.
   PubMed Web of Science ®Google Scholar
• Zhang, L., Q. Dai, L. Hu, H. Yu, J. Qiu, J. Zhou, M. Long, S. Zhou, and K. Zhang. 2020. Hyperoside alleviates high glucose-induced proliferation of mesangial cells through the inhibition of the erk/creb/mirna-34a signaling pathway. International Journal of Endocrinology 2020:1361924. doi: 10.1155/2020/1361924.
   PubMed Web of Science ®Google Scholar
• Zhang, L., S. He, F. Yang, H. Yu, W. Xie, Q. Dai, D. Zhang, X. Liu, S. Zhou, and K. Zhang. 2016. Hyperoside ameliorates glomerulosclerosis in diabetic nephropathy by downregulating mir-21. Canadian Journal of Physiology and Pharmacology 94 (12):1249–56. doi: 10.1139/cjpp-2016-0066.
   PubMed Web of Science ®Google Scholar
• Zhang, M., X. Wang, M. Liu, D. Liu, J. Pan, J. Tian, T. Jin, Y. Xu, and F. An. 2020. Inhibition of phlpp1 ameliorates cardiac dysfunction via activation of the pi3k/akt/mtor signalling pathway in diabetic cardiomyopathy. Journal of Cellular and Molecular Medicine 24 (8):4612–23. doi: 10.1111/jcmm.15123.
   PubMed Web of Science ®Google Scholar
• Zhang, S., L. Xu, R. Liang, C. Yang, and P. Wang. 2020. Baicalin suppresses renal fibrosis through microrna-124/tlr4/nf-κb axis in streptozotocin-induced diabetic nephropathy mice and high glucose-treated human proximal tubule epithelial cells. Journal of Physiology and Biochemistry 76 (3):407–16. doi: 10.1007/s13105-020-00747-z.
   PubMed Web of Science ®Google Scholar
• Zhang, S., R. Xue, and R. Hu. 2020. The neuroprotective effect and action mechanism of polyphenols in diabetes mellitus-related cognitive dysfunction. European Journal of Nutrition 59 (4):1295–311. doi: 10.1007/s00394-019-02078-2.
   PubMed Web of Science ®Google Scholar
• Zhang, Z.-Z., X.-H. Qin, and J. Zhang. 2019. Microrna-183 inhibition exerts suppressive effects on diabetic retinopathy by inactivating btg1-mediated pi3k/akt/vegf signaling pathway. American Journal of Physiology. Endocrinology and Metabolism 316 (6):E1050–E1060. doi: 10.1152/ajpendo.00444.2018.
   PubMed Web of Science ®Google Scholar
• Zheng, D., J. Ma, Y. Yu, M. Li, R. Ni, G. Wang, R. Chen, J. Li, G. C. Fan, J. C. Lacefield, et al. 2015. Silencing of mir-195 reduces diabetic cardiomyopathy in c57bl/6 mice. Diabetologia 58 (8):1949–58. doi: 10.1007/s00125-015-3622-8.
   PubMed Web of Science ®Google Scholar
• Zhou, H., W. J. Ni, X. M. Meng, and L. Q. Tang. 2020. Micrornas as regulators of immune and inflammatory responses: potential therapeutic targets in diabetic nephropathy. Frontiers in Cell and Developmental Biology 8:618536. doi: 10.3389/fcell.2020.618536.
   PubMed Web of Science ®Google Scholar
• Zhou, Q., D. Lv, P. Chen, T. Xu, S. Fu, J. Li, and Y. Bei. 2014. Micrornas in diabetic cardiomyopathy and clinical perspectives. Frontiers in Genetics 5:185. doi: 10.3389/fgene.2014.00185.
   PubMed Web of Science ®Google Scholar
• Zhou, Z., J. Wan, X. Hou, J. Geng, X. Li, and X. Bai. 2017. Microrna-27a promotes podocyte injury via pparγ-mediated β-catenin activation in diabetic nephropathy. Cell Death & Disease 8 (3):e2658. doi: 10.1038/cddis.2017.74.
   PubMedGoogle Scholar